Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability. Operating Expenses Cut 70% as Turnaround Gains Traction Marpai,Inc. (“Marpai” or the “Company”) (OTCQX: MRAI),a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced second quarter 2025 results that mark a decisive step forward in its turnaround strategy. The […]
~ Recently Announced Strategic Acquisition of SiVantage Portfolio Energizes Tenon’s Commercial Organization and Accelerates Topline Growth ~ ~ FDA Clearance Unlocks New Sacro-Pelvic Market Opportunity for Catamaran® as Adjunct to Thoracolumbar Fixation with Initial Case Series Successfully Completed ~ ~ Operating Expenses Down 29% Year-over-Year as Company Advances Toward Integration of SiVantage Assets, Addition of
(NASDAQ:FOSL), Delivers positive operating income Second quarter 2025 worldwide net sales totaled $220 million Gross margin expanded 490 basis points to 57.5% Second quarter operating income of $8 million and operating margin of 3.9%; constant currency adjusted operating income of $4 million and constant currency adjusted operating margin of 1.7% Raises full year 2025 guidance
(NASDAQ:DLO), MONTEVIDEO, Uruguay, Aug. 13, 2025 (GLOBE NEWSWIRE) — DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology – first payments platform, today announced the appointment of Guillermo Lopez Perez as Chief Financial Officer, who will join us in the next few months. Guillermo will report to dLocal's CEO, Pedro Arnt. This appointment further
(NASDAQ:JSPR), REDWOOD CITY, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today reported results for
(NASDAQ:MDLZ), CHICAGO, Aug. 13, 2025 (GLOBE NEWSWIRE) — MondelÄ”z International, Inc. (Nasdaq: MDLZ) today announced that Dirk Van de Put, Chief Executive Officer and Luca Zaramella, Chief Financial Officer, will participate in a fireside chat session at the Barclays Global Consumer Staples Conference on Wednesday, September 3, 2025, at 8:15 am ET. A live audio
Fossil Group, Inc. Reports Second Quarter 2025 Financial Results GlobeNewswire August 13, 2025 Delivers positive operating income Second quarter 2025 worldwide net sales totaled $220 million Gross margin expanded 490 basis points to 57.5% Second quarter operating income of $8 million and operating margin of 3.9%; constant currency adjusted operating income of $4 million and
Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire August 13, 2025 REDWOOD CITY, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such
Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025. https://mma.prnewswire.com/media/320376/accuray_incorporated_logo.jpg Key Fiscal Fourth Quarter Highlights — Net revenue was $127.5 million, a decrease of 5 percent from the prior year period. — Net income was
https://mma.prnewswire.com/media/813707/Cisco_v2_Logo.jpg News Summary: — Strong topline performance at the high end of our guidance ranges: — Q4 revenue of $14.7 billion, up 8% year over year — FY 2025 revenue of $56.7 billion, up 5% year over year — Q4 product orders up 7% year over year with growth across all geographies, demonstrating robust demand